Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: Novel valdecoxib derivatives by ruthenium(II)-promoted 1,3-dipolar cycloaddition of nitrile oxides with alkynes – synthesis and COX-2 inhibition activity
Silvia
Roscales
a,
Nicole
Bechmann
a,
Daniel Holger
Weiss
b,
Martin
Köckerling
b,
Jens
Pietzsch
ac and
Torsten
Kniess
*a
aDepartment of Radiopharmaceutical and Chemical Biology, Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Bautzner Landstraße 400, 01328 Dresden, Germany. E-mail: t.kniess@hzdr.de
bDepartment of Inorganic Solid State Chemistry, Institute of Chemistry, University of Rostock, Albert Einstein Straße 3a, 18059 Rostock, Germany
cDepartment of Chemistry and Food Chemistry, Technische Universität Dresden, Bergstraße 66, 01062 Dresden, Germany
First published on 7th March 2018
Abstract
Correction for ‘Novel valdecoxib derivatives by ruthenium(II)-promoted 1,3-dipolar cycloaddition of nitrile oxides with alkynes – synthesis and COX-2 inhibition activity’ by Silvia Roscales et al., Med. Chem. Commun., 2018, DOI: 10.1039/c7md00575j.
The authors regret that the structure of compound 1c in Scheme 4 was not correct. The corrected structure is shown below.
 | ||
| Scheme 4 | ||
Also, the name of compound 1f was not correct in the Electronic Supplementary Information file. 3-[4-(Methylsulfonyl)phenyl]propioaldehyde has been corrected to 3-[4-(methylsulfonyl)phenyl]prop-2-ynal and the corrected file has been uploaded to replace the original file.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2018 |